Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies
Acquisition supports Roche’s Pharma Strategy and allows for a range of potentially first and best-in-class therapies across oncology, immunology, and neurology, uniquely positioning Roche in the new field of donor-derived off-the-shelf cell therapies Roche to acquire Poseida Therapeutics for US $9.00 per share in cash at closing, representing a total equity value of approximately US […]
Roche reports update on Phase III SKYSCRAPER-01 study results
Basel, 26 November 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) reports an update on the phase III SKYSCRAPER-01 study, evaluating tiragolumab combined with Tecentriq® (atezolizumab) compared to Tecentriq alone for patients with PD-L1-high, locally advanced or metastatic non-small cell lung cancer (NSCLC). SKYSCRAPER-01 is a global phase III, randomised, double-blind study evaluating tiragolumab plus […]
WHO adds LC16m8 mpox vaccine to Emergency Use Listing
WHO and partners rally cervical cancer elimination efforts
Geneva---As world leaders arrive in Rio de Janeiro, Brazil, for the G20 Summit this weekend, the city’s iconic Christ the Redeemer statue will be illuminated in the colour teal. The Brazilian advocates behind this effort are among many around the globe joining the World Health Organization (WHO) to mobilize efforts on a worldwide “Day of […]
The Department of Pharmaceuticals Successfuly completes Special Campaign 4.0
The Department of Pharmaceuticals actively participated in the Special Campaign 4.0 of the Government from 2nd October, 2024 to 31st October, 2024. Special focus was given on activities of organisations of the Department, namely National Pharmaceutical Pricing Authority (NPPA); National Institutes of Pharmaceutical Education and Research (NIPERs) at Ahmedabad, SAS Nagar, Rae Bareli, Hajipur, Kolkata, […]
Countries pledge to act on childhood violence affecting some 1 billion children
7 November 2024, Bogotá -- More than 100 governments today made historic commitments to end childhood violence, including nine pledging to ban corporal punishment – an issue that affects 3 out of every 5 children regularly in their homes. These commitments were made at a landmark event in Bogotá, Colombia, where government delegations are set […]
Second round of polio campaign in Gaza completed amid ongoing conflict and attacks: UNICEF and WHO
East Jerusalem/Amman/Geneva/New York - The second round of the polio vaccination campaign in the Gaza Strip was completed yesterday, with an overall 556 774 children under the age of 10 being vaccinated with a second dose of polio vaccine, and 448 425 children between 2- to 10-years-old receiving vitamin A, following the three phases conducted […]
Roche to present new and encouraging long-term follow-up data across broad haematology portfolio at ASH 2024
Basel, 05 November 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more than 40 abstracts across nine blood disorders at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, held 7-10 December 2024 in San Diego, US. The data underscore Roche’s commitment to advance patient outcomes in […]
Roche to present new and encouraging long-term follow-up data across broad haematology portfolio at ASH
Basel, 05 November 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more than 40 abstracts across nine blood disorders at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, held 7-10 December 2024 in San Diego, US. The data underscore Roche’s commitment to advance patient outcomes in […]
Positive phase III results show Xofluza significantly reduces the transmission of influenza viruses
Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza from an infected person to household members This is the first time that any antiviral used in the treatment of a respiratory viral illness has demonstrated a transmission reduction benefit in a global phase III study Reducing the spread of infection in the […]
